TGFB1 and intervertebral disk degenerative disorder: Henry et al. developed a biphasic injectable hydrogel system that serves as a vehicle for sustained release of TGF-β1 and GDF-5, allowing their sustained release to prevent the growth factors from degradation during the treatment of disc degeneration [55].